Oliver Luxxe Assets LLC acquired a new stake in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 8,526 shares of the aerospace company’s stock, valued at approximately $1,228,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Fiduciary Trust Co boosted its stake in shares of Leidos by 36.4% in the third quarter. Fiduciary Trust Co now owns 23,941 shares of the aerospace company’s stock valued at $3,902,000 after buying an additional 6,395 shares in the last quarter. Atria Investments Inc grew its stake in shares of Leidos by 100.1% during the 3rd quarter. Atria Investments Inc now owns 8,837 shares of the aerospace company’s stock worth $1,440,000 after purchasing an additional 4,421 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of Leidos by 51.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock valued at $136,491,000 after purchasing an additional 283,558 shares in the last quarter. Los Angeles Capital Management LLC boosted its holdings in Leidos by 21.4% during the third quarter. Los Angeles Capital Management LLC now owns 55,165 shares of the aerospace company’s stock worth $8,992,000 after buying an additional 9,710 shares in the last quarter. Finally, Rockefeller Capital Management L.P. purchased a new stake in Leidos during the third quarter worth about $4,622,000. Institutional investors and hedge funds own 76.12% of the company’s stock.
Leidos Price Performance
Shares of NYSE:LDOS opened at $148.25 on Tuesday. The company has a market cap of $19.78 billion, a P/E ratio of 16.88, a P/E/G ratio of 1.04 and a beta of 0.66. The business has a fifty day simple moving average of $164.26 and a 200-day simple moving average of $157.82. Leidos Holdings, Inc. has a 52 week low of $107.73 and a 52 week high of $202.90. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87.
Leidos Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date of this dividend was Monday, December 16th. This is a positive change from Leidos’s previous quarterly dividend of $0.38. Leidos’s dividend payout ratio (DPR) is 18.22%.
Insider Activity
In other Leidos news, Director Noel B. Geer purchased 2,000 shares of Leidos stock in a transaction on Wednesday, November 20th. The shares were purchased at an average cost of $161.13 per share, with a total value of $322,260.00. Following the completion of the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $322,260. This represents a ? increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total transaction of $193,632.18. Following the completion of the sale, the director now directly owns 6,408 shares of the company’s stock, valued at $1,185,095.52. The trade was a 14.04 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company reduced their price target on shares of Leidos from $230.00 to $205.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Royal Bank of Canada upped their target price on Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a report on Wednesday, October 30th. JPMorgan Chase & Co. lifted their price target on Leidos from $175.00 to $185.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. UBS Group began coverage on shares of Leidos in a research note on Monday, December 2nd. They issued a “neutral” rating and a $182.00 price objective on the stock. Finally, Citigroup lifted their target price on shares of Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Leidos has a consensus rating of “Moderate Buy” and a consensus target price of $182.00.
View Our Latest Research Report on LDOS
Leidos Company Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Stories
- Five stocks we like better than Leidos
- How to Invest in Insurance Companies: A GuideĀ
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- 3 Healthcare Dividend Stocks to Buy
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Conference Calls and Individual Investors
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding LDOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Leidos Holdings, Inc. (NYSE:LDOS – Free Report).
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.